Administered and endogenously released kappa opioids decrease pilocarpine-induced seizures and seizure-induced histopathology

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 3, 1998, Pages 1147-1155

  Bausch, Suzanne B ^a,c   Esteb, Tiffany M ^a   Terman, Gregory W ^b   Chavkin, Charles ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; KAPPA OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NORBINALTORPHIMINE; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT THERAPY; ARTICLE; CELL SURVIVAL; DENTATE GYRUS; DRUG EFFECT; DRUG POTENCY; EXCITATORY POSTSYNAPTIC POTENTIAL; GROWTH INHIBITION; HIPPOCAMPUS; LATENT PERIOD; MALE; MOSSY FIBER; NERVE CELL GROWTH; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION; TEMPORAL LOBE EPILEPSY;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; DENTATE GYRUS; MALE; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SEIZURES;

EID: 0031913186     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Babb T and Brown W (1987) Pathological findings in epilepsy, in Surgical Treatment of the Epilepsies (Engel J, ed) pp 511-540, Raven Press, New York.
2. Baez LA, Eskridge NK and Schein R (1976) Postnatal development of dopaminergic and cholinergic catalepsy in the rat. Eur J Pharmacol 36:155-162.
3. Bausch SB and Chavkin C (1997) Changes in hippocampal circuitry following pilocarpine-induced seizures as revealed by opioid receptor distribution and activation. J Neurosci 17:477-492.
4. Bianchi G (1989) High-performance liquid Chromatographic assay of κ-opioid selective benzeneacetamide derivatives (U50488, U69593 and PD117302) in rat plasma and brain. J Chromatogr 491:481-487.
5. Bramham CR, Errington ML and Bliss TVP (1988) Naloxone blocks the induction of long-term potentiation in the lateral but not the medial perforant pathway in the anesthetized rat. Brain Res 449:352-356.
6. Bramham CR, Milgram NW and Srebro B (1991) δ Opioid receptor activation is required to induce LTP of synaptic transmission in the lateral perforant path in vivo. Brain Res 567:42-50.
7. Caudle RM, Wagner JJ and Chavkin C (1991) Endogenous opioids released from perforant path modulate norepinephrine actions and inhibitory postsynaptic potentials in guinea pig CA3 pyramidal cells. J Pharmacol Exp Ther 258:18-26.
8. Chavkin C, James I and Goldstein A (1982) Dynorphin is a specific endogenous ligand for the kappa opioid receptor. Science 215:413-415.
9. Corbett A, Paterson S, McKnight A, Magnan J and Kosterlitz H (1982) Dynorphin (1-8) and dynorphin (1-9) are ligands for the kappa-subtype of opiate receptor-Nature 299:79-81.
10. DeCoster MA, Conover JR, Hunter JC and Tortella FC (1994) The neuroprotective κ-opioid CI-977 alters glutamate-induced calcium signaling in vitro NeuroReport 5:2305-2310.
11. Dingledine R, Dodd J and Kelly JS (1980) The in vitro brain slice as a useful neurophysiological preparation for intracellular recording. J Neurosci Meth 2:323-362.
12. Elwes RDS, Johnson AL, Shovron AD and Reynolds EH (1984) The prognosis for seizure control in newly diagnosed epilepsy. N Engl J Med 311:944-947.
13. Gannon RL and Terrian DM (1991) U-50,488H inhibits dynorphin and glutamate release from guinea pig hippocampal mossy fiber terminals. Brain Res 548:242-247.
14. Hall ED and Pazara KE (1988) Quantitative analysis of effects of k-opioid agonists on postischemic hippocampal CA1 neuronal necrosis in gerbils. Stroke 19:1008-1012.
15. Hauser WA and Kurland L (1975) The epidemiology of epilepsy in Rochester, Minnesota, 1935-1937. Epilepsia 16:1-66.
16. Hayes AG, Birch PP and Cavicchini E (1988) Evidence that the kappa agonist U50488H has non-opioid actions. J Pharm Pharmacol 40:718-720.
17. Hayward NJ, McKnight AT and Woodruff GN (1992) The neuroprotective action of κ-opioid agonists in the gerbil. Mol Neuropharmacol 2:221-227.
18. Holm IE and Geneser FA (1991) Histochemical demonstration of zinc in the hippocampal region of the domestic pig: III. The dentate area. J Comp Neural 308:409-417.
19. Hong JS, Wood PL, Gillan JC, Yang HYT and Costa E (1980) Changes of hippocampal met-enkephalin content after recurrent motor seizures. Nature 285:231-232.
20. Houser CR, Miyashiro JE, Swartz BE, Walsh GO, Rich JR and Delgado-Escueta AV (1990) Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy. J Neurosci 10:267-282.
21. Kanamatsu T, McGinty J, Mitchell C and Hong JS (1986a) Dynorphin-and enkephalin-like immunoreactivity is altered in limbic-basal ganglia regions of rat brain after electroconvulsive shock. J Neurosci 6:644-649.
22. Kanamatsu T, Obie J, Grimes L, McGinty JF, Yoshikawa K, Sabol S and Hong JS (1986b) Kainic acid alters the metabolism of met5-enkephalin and the level of dynorphin A in the rat hippocampus. J Neurosci 6:3094-3102.
23. Lahti RA, VonVoigtlander PF and Barsuhn C (1982) Properties of a selective kappa agonist, U-50, 488H. Life Sci 31:2257-2260.
24. 3H]U-69593 a highly selective ligand for the opioid κ receptor. Eur J Pharmacol 109:281-284.
25. Laurberg S and Zimmer J (1981) Lesion-induced sprouting of hippocampal mossy fiber collaterals to the fascia dentata in developing and adult rats. J Comp Neurol 200:433-459.
26. Leyton M and Stewart J (1992) The stimulation of central κ opioid receptors decreases male sexual behavior and locomotor activity. Brain Res 594:56-74.
27. MacKay KB, Kusumoto K, Graham DI and McCulloch J (1993) Effect of the kappa-1 opioid agonist CI-977 on ischemic brain damage and cerebral blood flow after middle cerebral artery occlusion in the rat. Brain Res 629:10-18.
28. Mansour A, Khachaturian H, Lewis ME, Akil H and Watson SJ (1988) Anatomy of CNS opioid receptors. Trends Neurol Sci 11:308-314.
29. Margerison JH and Corsellis JA (1966) Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 89:499-530.
30. Mattsen RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, Williamson, PD, Treiman DM, McNamara JO, McCutchen CB, Homan RW, Crill WE. Lubozynski MF, Rosenthal NP and Mayersdorf A (1985) Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 313:145-151.
31. McFadzean I, Lacey MG, Hill RG and Henderson G (1988) Kappa opioid receptor activation depresses excitatory input to rat locus coeruleus neurons in vitro. Neuroscience 20:231-239.
32. McGinty JF, Bohler WT, Patterson TA and Chavkin C (1994) Kappa receptor immunoreactivity is present in cells and fibers of the rat forebrain. Regul Pept 54:185-186.
33. McLean S, Rothman RB, Jacobson AE, Rice KC and Herkenham M (1987) Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat, and hamster. J Comp Neurol 255:497-510.
34. Mello LEAM, Cavalheiro EA, Tan AM, Kupfer WR, Pretorius JK, Babb TL and Finch DM (1993) Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: Cell loss and mossy fiber sprouting. Epilepsia 34:985-995.
35. Mello LEAM, Cavalheiro EA, Tan AM, Pretorius JK, Babb TL and Finch DM (1992) Granule cell dispersion in relation to mossy fiber sprouting, hippocampal cell loss, silent period and seizure frequency in the pilocarpine model of temporal lobe epilepsy, in Molecular Neurobiology of Epilepsy (Engel Jr J, Wasterlain C, Cavalheiro EA, Heinemann U and Avanzinipp G, eds) Epilepsy Res. Suppl. 9, pp 51-60, Elsevier Science Publishers BV, Amsterdam.
36. Milanes MV, Gonzalvez ML, Fuente T and Vargas ML (1991) Pituitary-adrenocortical response to acute and chronic administration of U-50488H in the rat. Neuropeptides 20:95-102.
37. Moore SD, Madamba SG, Zieglgansberger W and Siggins GR (1988) Enkephalin analogues depress synaptic potentials in rat dentate granule cells recorded intracellularly in vitro. Neuroci Lett 91:71-76.
38. Nadler JV, Perry BW and Cotman CW (1980) Selective reinnervation of hippocampal CA1 and the fascia dentata after destruction of CA3-CA4 afferents with kainic acid. Brain Res 182:1-9.
39. Nencini P and Graziani M (1990) Opiatergic modulation of preparatory and consummatory components of feeding and drinking. Pharmacol Biochem Behav 37:531-537.
40. Neumaier JF, Mailheau S and Chavkin C (1988) Opioid receptor-mediated responses in the dentate gyrus and CA1 region of the rat hippocampus, J Pharmacol Exp Ther 244:564-570.
41. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press Australia, Sydney.
42. Przewloka B, Machelska H and Lason W (1994) Kappa opioid receptor agonists inhibit pilocarpine-induced seizures and toxicity in the mouse. Eur Neuropsychpharmacol 4:527-533.
43. Ribak CE and Peterson GM (1991) Intragranular mossy fibers in rats and gerbils form synapses with the somata and proximal dendrites of basket cell in the dentate gyrus. Hippocampus 1:355-364.
44. Salin PA, Weisskopf MG and Nicoll RA (1995) A comparison of the role of dynorphin in the hippocampal mossy fiber pathway in guinea pig and rat. J Neurosci 15: 6939-6945.
45. Seress L (1992) Morphological variability and developmental aspects of monkey and human granule cells: Differences between the rodent and primate dentate gyrus, in The Dentate Gyrus and Its Role in Seizures (Ribak CE, Gall CM and Mody I, eds) Epilepsy Res. Suppl. 7, pp 3-28, Elsevier Science Publishers BV, Amsterdam.
46. Simmons ML, Terman GW and Chavkin C (1997) Spontaneous excitatory currents and kappa opioid receptor inhibition in dentate gyrus are increased in the rat pilocarpine model of temporal lobe epilepsy. J Neurophysiol 78:1860-1868..
47. Simmons ML and Chavkin C (1996) Endogenous opioid regulation of hippocampal function, Int Rev Neurobiol 39:146-197.
48. Simmons ML, Drake CT, Terman GW and Chavkin C (1994) Inhibition of glutamate release by presynaptic kappal opioid receptors in the guinea pig dentate gyrus. J Neurophysiol 72:1697-1705.
49. Simmons ML, Wagner JJ, Caudle RM and Chavkin C (1992) Endogenous opioid regulation of norepinephrine release in guinea pig hippocampus. Neurosci Lett 141:84-88.
50. Spencer RL, Hruby VJ and Burks TF (1988) Body temperature response profiles for selective mu, delta and kappa opioid agonists in restrained and unrestrained rats. J Pharmacol Exp Ther 246:92-101.
51. Sutula T, Cascino G, Cavazos J, Parada I and Ramirez L (1989) Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol 26:321-330.
52. Takemori AE, Ho BY, Naeseth JS and Portoghese PS (1988a) Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther 246:255-258.
53. Takemori AE, Schwartz MM and Portoghese PS (1988b) Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats. J Pharmacol Exp Ther 247:971-974.
54. Tauck DL and Nadler JV (1985) Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. J Neurosci 5:1016-1022.
55. Tortella FC (1988) Endogenous opioid peptides and epilepsy: Quieting the seizing brain. Trends Pharmacol Sci 9:366-372.
56. Turski WA, Cavalheiro EA, Schwarz M, Czuczwar SJ, Kleinrok Z and Turski L (1983) Limbic seizures caused by pilocarpine in rats: a behavioral, electroencephalographic and neuropathological study. Behau Brain Res 9:315-336.
57. Turski L, Ikonomidou C, Cavalheiro EA, Kleinrok Z, Czuczwar SJ and Turski WA (1985) Effects of morphine and naloxone on pilocarpine-induced convulsions in rats. Neuropeptides 5:315-318.
58. Turski L, Ikonomidou C, Turski WA, Bortolotto ZA and Cavalheiro EA (1989) Review: Cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: A novel experimental model of intractable epilepsy. Synapse 3:154-171.
59. Utz J, Eckert R and Trautwein W (1995) Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the κ-opioid agonist U50488H does not involve binding to opioid receptors. J Pharmacol Exp Ther 274:627-633.
60. Veeranna PLR and Bhargava HN (1993) Effect of chronic administration of U-50,488H, a κ-opioid receptor agonist, on central dopamine D2 receptors of the rat. Eur J Pharmacol 235:23-30.
61. VonVoigtlander PF, Lahti RA and Ludens JH (1983) U-50,488: A selective and structurally novel non-mu (kappa) opioid agonist. J Pharmacol Exp Ther 224:7-12.
62. Wagner JJ, Caudle RM, Neumaier JF and Chavkin C (1990) Stimulation of endogenous opioid release displaces mu receptor binding in rat hippocampus. Neuroscience 37:45-53.
63. Wagner JJ, Evans CJ and Chavkin C (1991) Focal stimulation of the mossy fibers releases endogenous dynorphins that bind κ1-opioid receptors in guinea pig hippocampus. J Neurochem 57:333-343.
64. Wagner JJ, Caudle RM and Chavkin C (1992) κ-Opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus. J Neurosci 12:132-141.
65. Wagner JJ, Terman GW and Chavkin C (1993) Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature 363:451-454.
66. Weisskopf MG, Zalutsky RA and Nicoll RA (1993) The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 362:423-427.
67. Widmayer MA, Turner TD, Browning JL and Baskin DS (1994) U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia. Mol Chem Neuropathol 22:211-223.
68. Xie C-W and Lewis DV (1991) Opioid-mediated facilitation of long-term potentiation at lateral perforant path-dentate granule cell synapse. J Pharmacol Exp Ther 256:289-296.
69. Xie C-W and Lewis DV (1995) Endogenous opioids regulate long-term potentiation of synaptic inhibition in the dentate gyrus of rat hippocampus. J Neurosci 15:3788-3795.
70. Zukin RS, Eghbali M, Olive D, Unterwald EM and Tempel A (1988) Characterization and visualization of rat and guinea pig brain kappa opioid receptors: Evidence for kappal and kappa2 opioid receptors. Proc Natl Acad Sci. USA 85:4061-4065.